Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed beyond the "point of no return" after just a few ...
The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA). Colonies of the bacterium Bacillus anthracis, which causes anthrax, at 10x ...